2008 annual financial data
Nektar Therapeutics 2008 Net margin
Direct answer
Net margin was -38.07%.
Operating income was -82,652,000 USD and net income was -34,336,000 USD.
Operating cash flow was -145,782,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 90,185,000 USD
- Operating income
- -82,652,000 USD
- Net income
- -34,336,000 USD
- Operating cash flow
- -145,782,000 USD